Type 2 diabetes
Trial win sets up filings for Lilly’s diabetes blockbuster hope tirzepatide
Phil Taylor
Diabetes, Eli Lilly, Novo Nordisk, Ozempic, tirzepatide, Trulicity, Type 2 diabetes
0 Comment
Better Therapeutics begins ‘real world’ study of digital diabetes therapy
Richard Staines
Better Therapeutics, digital health, digital therapeutics, Type 2 diabetes
0 Comment
Bayer data for kidney disease hope finerenone sets up filings
Phil Taylor
AstraZeneca, Bayer, chronic kidney disease, Farxiga, finerenone, Invokana, Johnson & Johnson, SGLT2 inhibitors, Type 2 diabetes
0 Comment
Novo launches type 2 diabetes pill in UK after NICE waives review
Richard Staines
market access, NICE, Novo Nordisk, Type 2 diabetes
0 Comment
Digital/ News/ News/ News/ Patients
NHS backs free behavioural change app for type 2 diabetics
Phil Taylor
Changing Health, Diabetes, digital, NHS, Type 2 diabetes
0 Comment
FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidney disease
Phil Taylor
Boehringer Ingelheim, chronic kidney disease, Eli Lilly, Jardiance, Type 2 diabetes
0 Comment
Market Access/ News/ News/ News/ Sales and Marketing
Lilly, Boehringer bag FDA okay for diabetes triple Trijardy XR
Phil Taylor
Boehringer Ingelheim, combination therapy, Eli Lilly, metabolic disease, Type 2 diabetes
0 Comment
AZ’s Forxiga gets heart claim data on its EU label
Phil Taylor
AstraZeneca, cardiovascular outcomes, Forxiga, SGLT2 inhibitors, Type 2 diabetes
0 Comment